PMID: 11907950Mar 23, 2002Paper

Autoimmune hepatitis. Physiopathologic, clinical, histological, and therapeutic features

Annales de médecine interne
J C Duclos-ValléeA M Yamamoto

Abstract

Autoimmune hepatitis is characterized by an inflammation of the portal tract with lymphocytes and plasma cells, an hypergammaglobulinemia and a variety of circulating autoantibodies. The presence of smooth muscle antibodies and/or antinuclear antibodies define type 1. Type 2 is characterized by the presence of liver-kidney--microsomal antibodies. Environmental, genetic and infectious factors may explain the autoreactivity of T cells. Different non specific clinical features may be present. Sometimes the presentation may be an acute hepatitis; in the remainder, the disease may not be recognized until liver damage is advanced. Hypergammaglobulinemia and presence of circulating autoantibodies are the key for diagnosis. The association of prednisolone in combination with azathioprine remains the established treatment. If relapse or non response occur, other immunosuppressive therapy such as cyclosporin may be useful. Liver transplantation is reserved for (sub)fulminant forms and end stage liver disease.

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Related Papers

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Vaibhav MehendirattaSteven K Herrine
Therapeutische Umschau. Revue thérapeutique
Michael Christian Sulz, Tilman Jörn Gerlach
La Revue du praticien
O Marcais, D Larrey
Indian Journal of Pediatrics
E A Roberts
Therapeutische Umschau. Revue thérapeutique
M H Heim
© 2022 Meta ULC. All rights reserved